Jane Panteleev
5Patents
3h-index
25Co-inventors
49Inventor score
Filing activity: Oct 18, 2018 → Sep 21, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11608344B2 | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use | Chemistry; Metallurgy | 3 | Active |
| US11912711B2 | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use | Chemistry; Metallurgy | 3 | Active |
| US11884675B2 | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use | Chemistry; Metallurgy | 3 | Active |
| US11332459B2 | Benzimidazole derivatives and their uses | Chemistry; Metallurgy | 0 | Active |
| US12428425B2 | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.